Japan Medical Dynamic Marketing recorded a share price development of -4.64 percent over the last twelve months. In comparison, similar companies in the healthcare services industry rose by an average of 3.1 percent. This leads to an underperformance of -7.75 percent compared to the industry environment. The entire healthcare sector achieved an average return of -3.96 percent, which positions Japan Medical Dynamic Marketing 0.69 percent below the average. This comparatively similar return in the sector and the underperformance compared to the industry result in a rating of “neutral” for the stock.
In terms of investor sentiment, the analysis of the mood and the intensity of discussions in the past month showed no significant changes. Therefore, this aspect is also rated as “neutral”. Investors have not discussed the company more or less, which leads to a further rating of the Japan Medical Dynamic Marketing share in the “neutral” range.
The Relative Strength Index (RSI), a well-known technical analysis tool for assessing whether a stock is overbought or oversold, is viewed for both a seven-day and a 25-day period. The 7-day RSI is currently at 44,444 points, which indicates that the stock is neither overbought nor oversold and is therefore classified as “neutral.” The situation is similar with the 25-day RSI, which at 48,746 points also indicates that the stock is neutral in this category.
From a fundamental perspective, Japan Medical Dynamic Marketing’s price-earnings ratio (P/E) is 13. Compared to the healthcare industry, which has an average P/E of 21.53, Japan Medical Dynamic Marketing is about 35 percent below this average. From a fundamental perspective, the stock is considered undervalued, which leads to a positive rating of “Good”.
Buy, hold or sell – your Japan Medical Dynamic Marketing analysis from September 24th provides the answer:
How will Japan Medical Dynamic Marketing develop now? Is it worth getting involved or should investors sell? You can find out the answers to these questions and why you need to act now in the current Japan Medical Dynamic Marketing analysis.
Japan Medical Dynamic Marketing: Buy or sell? Read more here…
